In patients with metastatic lung SCC who are on pembrolizumab maintenance after starting pembrolizumab/carboplatin/nab-paclitaxel, what is your treatment strategy if they progress while on pembrolizumab alone?
Would you continue pembrolizumab with a re-challenge with carboplatin/taxane or move to second line therapy?
I agree with Dr. @Stephen V. Liu. If the response...
We've also continued IO and added a dash of radiat...